<DOC>
	<DOCNO>NCT01711710</DOCNO>
	<brief_summary>The aim study evaluate safety efficacy Cohesive Silicone Gel-Filled Breast Implant ( CoSBI ) produce HansBiomed co. , Ltd . breast reconstruction augmentation</brief_summary>
	<brief_title>Clinical Trial Evaluate Safety Efficacy Breast Implant</brief_title>
	<detailed_description />
	<criteria>Over 22 year age Subjects want breast augmentation reconstruction follow breast cancer , congenital accidental unbalance breast size Negative pregnancy test fertile woman Subjects voluntarily decide participation study sign informed consent Subjects understand comply instruction participate entire period trial previous breast reconstruction augmentation history self immune disease uncontrolled active infectious disease unable insert beast implant due radiotherapy Patients recurrent breast cancer treat effectively cancer Keloid Abnormal blood test ECG result general anesthesia Patients MRI scan due Metallic substance body Claustrophobia Aesthetic addiction , drug abuse , alcohol abuse Patients eligible study medical discretion Principal Investigator Subinvestigator</criteria>
	<gender>Female</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Breast cancer</keyword>
	<keyword>reconstruction</keyword>
	<keyword>augmentation</keyword>
	<keyword>cohesive silicone gel</keyword>
	<keyword>breast implant</keyword>
	<keyword>rupture</keyword>
	<keyword>capsular contracture</keyword>
</DOC>